Cargando…
Gestational Diabetes Mellitus Resulting From Impaired β-Cell Compensation in the Absence of FoxM1, a Novel Downstream Effector of Placental Lactogen
OBJECTIVE: The objectives of the study were to determine whether the cell cycle transcription factor, FoxM1, is required for glucose homeostasis and β-cell mass expansion in maternal islets during pregnancy and whether FoxM1 is essential for placental lactogen (PL)-induced β-cell proliferation. RESE...
Autores principales: | Zhang, Hongjie, Zhang, Jia, Pope, Christine F., Crawford, Laura A., Vasavada, Rupangi C., Jagasia, Shubhada M., Gannon, Maureen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797915/ https://www.ncbi.nlm.nih.gov/pubmed/19833884 http://dx.doi.org/10.2337/db09-0050 |
Ejemplares similares
-
β-Cell Proliferation, but Not Neogenesis, Following 60% Partial Pancreatectomy Is Impaired in the Absence of FoxM1
por: Ackermann Misfeldt, Amanda, et al.
Publicado: (2008) -
Human Placental Tissue Contains A Placental Lactogen–Derived Vasoinhibin
por: Markl-Hahn, Hülya, et al.
Publicado: (2022) -
Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer
por: Tuttle, Traci R., et al.
Publicado: (2014) -
Case–control study of prolactin and placental lactogen in SGA pregnancies
por: Ladyman, Sharon R, et al.
Publicado: (2021) -
Prenatal health behaviours as predictors of human placental lactogen levels
por: Garay, Samantha M., et al.
Publicado: (2022)